Drug Markets/Raltegravir

Raltegravir

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Raltegravir is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Raltegravir is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $34.52 to $34.54 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$34.52 – $34.54

per EA

7d Activity

1↑1↓0 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing RALTEGRAVIR

Drug Portfolio

2 NDCs total, 2 shown

Frequently Asked Questions

What is Raltegravir used to treat?

Raltegravir is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.

How many Raltegravir products are on the market?

The Raltegravir drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Raltegravir?

NADAC reference prices for Raltegravir range from $34.5150 to $34.5389 per EA — a 0% difference between cheapest and most expensive.

Which manufacturers make Raltegravir?

1 manufacturer lists Raltegravir in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (2).

How has the price of Raltegravir changed recently?

Over the past 7 days, 1 Raltegravir NDC rose and 1 fell, with a market-wide average change of +0.0%.